Pharming (PHAR) Receivables - Other (2019 - 2025)
Pharming's Receivables - Other history spans 7 years, with the latest figure at $1.9 million for Q4 2025.
- Quarterly results put Receivables - Other at $1.9 million for Q4 2025, up 21.05% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (up 21.05% YoY), and the annual figure for FY2025 was $1.9 million, up 21.05%.
- Receivables - Other for Q4 2025 was $1.9 million at Pharming, up from $1.6 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.4 million in Q4 2021 to a low of $1.1 million in Q4 2022.
- The 5-year median for Receivables - Other is $1.9 million (2025), against an average of $1.8 million.
- The sharpest move saw Receivables - Other plummeted 52.73% in 2022, then skyrocketed 92.03% in 2023.
- Year by year, Receivables - Other stood at $2.4 million in 2021, then plummeted by 52.73% to $1.1 million in 2022, then skyrocketed by 92.03% to $2.1 million in 2023, then decreased by 25.59% to $1.6 million in 2024, then increased by 21.05% to $1.9 million in 2025.
- According to Business Quant data, Receivables - Other over the past three periods came in at $1.9 million, $1.6 million, and $2.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.